InvestorsHub Logo

rawman

12/16/17 11:09 AM

#43119 RE: loanranger #43105

THE TAUG SHAREHOLDERS ARE NOW GOING TO BE WATCHING AND PERHAPS TOUTING ANOTHER ONE OF SETH SHAW'S "THROW CRAP AT A WALL, HOPING SOMETHING STICKS" ADVENTURES! IN A MACRO SENSE THE VTGN INVESTMENT IS NO DIFFERENT THAN GNIN, ITL, PILUS ENERGY, OR COWAN! INDEED, VTGN IS JUST ANOTHER ONE IN AN UNENDING LINE OF STABS AT WINNING A "LOTTERY"!

It appears Seth Shaw has finally concluded that he has no appetite to do the DD necessary to find an operating business, plus has also come to the realization he is ill-equipped to oversee an operating business!

TAUG is now what appears to be an accredited "Angel Investor"!

Seth Shaw spent just short of a half million acquiring the VTGN shares. The investors apparently have to assume this funding came out of the Cowan settlement. Add the half mil to the amounts paid to the accountants, lawyers, and "consultants", plus repaying the convertible debt, and POSSIBLY doing an "up to $150,000" share buy back (IMO...the buyback will never happen, because TAUG will once again be strapped for cash!). How much cash does TAUG have left from Cowan? Two days ago, paid consultant Johnny C claimed to know the Company's cash balance, but I believe he tacitly admitted this was "blowing more smoke"!

So now that TAUG has shares in a drug company, what is Seth Shaw's job! He pretty much sat around for two years, watching the lawyers and accountants do the actual work. Now TAUG has a significant investment in a drug company that may or may not payoff! The development "mystery" could go on for years before anyone has the slightest idea if the purported miracle drug might work! VTGN's lone FDA approval candidate is only in Phase 2a! There are hundreds of drug companies, touting optimism just like VTGN, and well over 90% of these will never make it to market! Anyone who has played the drugs stocks knows! Is TAUG going to become a drug stock "trader"? What is "CONSULTANT" Seth Shaw going to doing while the shareholders are waiting?

BTW...THERE ARE STILL MORE THAN 3 BILLION TAUG SHARES OUTSTANDING! SO MUCH FOR THE ANNOUNCED SHAREHOLDER "GAIN" FROM THE COWAN SETTLEMENT!

Johnny_C

12/19/17 9:34 AM

#43296 RE: loanranger #43105

Unbelievable. No business of its own worth talking about and TAUG takes a HUGE piece of his shareholder's nest egg and invests it in a drug development company with a single candidate in a Phase 2 trial.




Regarding TAUG's investment in VTGN: TAUG did make the investment in VTGN so it is very believable.

All the data so far is very positive. The NIH was so convinced of the potential that the original indication for pain was switched to depression. The NIH tripled the budget and fully funded phase 2a and some of the top depression people in the world are involved in the drug. Just on the patent approval the stock jumped from .70 to 2.5 and traded 65 million shares in two days.

There are several catalysts for VTGN by Q 2 2018 that could skyrocket the valuation and TAUG will be a huge winner controling 640,000 shares when the warrants are factored. Look for fast track designation, NIH results, new trials beginning for other indications and potential ventures with other pharma.


If TAUG management wanted to, they could make the VTGN investment a risk free transaction by selling the common and keeping the warrants for free on the next uptick. Moreover the stem cell division of VTGN is very exciting and VTGN shareholders may end up getting spin off shares of a new company if they choose to make that a stand alone NASDAQ company.

GAME SET MATCH TAUG